Shared Care Committee Polypharmacy Initiative

13
Shared Care Committee Polypharmacy Initiative Dr. Keith White “Awesome” Physician Lead, SCC Polypharmacy Initiative Clinical Lead, Medication Reconciliation BCPSQC

description

On January 18, 2013, the BC Patient Safety & Quality Council invited key stakeholders from across the province to join together in a day of meaningful discussion around: 1. The meaning of dignity in care, with a special focus on more appropriate use of antipsychotics; 2. The current state of antipsychotic use by people living in residential care in BC; 3. An overview of work currently underway throughout BC, nationally and internationally to identify opportunities for alignment as well as learning from others; 4. Envisioning an ideal state whereby more appropriate use of antipsychotic medications can be achieved; and 5. Framing a call to action that will ask teams from residential care facilities in BC to join our initiative. This is a presentation from the event delivered by Keith White, who is the BCPSQC’s Clinical Lead for Medication. Learn more about this initiative at http://www.bcpsqc.ca

Transcript of Shared Care Committee Polypharmacy Initiative

Page 1: Shared Care Committee Polypharmacy Initiative

Shared Care Committee Polypharmacy Initiative

Dr. Keith White“Awesome” Physician Lead, SCC Polypharmacy Initiative

Clinical Lead, Medication Reconciliation BCPSQC

Page 2: Shared Care Committee Polypharmacy Initiative

What is Polypharmacy?

Too many inappropriate medications?

Too many appropriate medications?

More than 5 medications?

More than 10 medications?

Page 3: Shared Care Committee Polypharmacy Initiative

Our Definition

When the theoretical benefits of multiple

medications are outweighed by the negative

effect of the sheer number of

medications, regardless of class of medication or

“appropriateness” thereof.

Page 4: Shared Care Committee Polypharmacy Initiative

Polypharmacy is a stand-

alone risk factor for

morbidity

Page 5: Shared Care Committee Polypharmacy Initiative

Polypharmacy: What We Know

Average number of meds in RC = 9

Affects Quality of Life & Resident Safety

Decreases in:• Global Health• Cognitive Function

Increases in:• ADE’s• Risk of Falls

Page 6: Shared Care Committee Polypharmacy Initiative

Adverse Drug Events

Lead to increased transfers to acute care• 5 or more 10%• 7 or more 20%• 9 or more 30%

Increase in transfers to acute care

Page 7: Shared Care Committee Polypharmacy Initiative

Hospitalization-Associated Disability

Hospitalization is a sentinel event that often precipitates disability. This results in the subsequent

inability to live independently and complete basic activities of daily living (ADLs).

This hospitalization-associated disability occurs in approximately 1/3 of patients >70 years of age and

may be triggered even when the illness that necessitated the hospitalization is successfully

treated.

Page 8: Shared Care Committee Polypharmacy Initiative

Polypharmacy itself should be conceptually perceived as “a disease,”

with potentially more serious complications than those of the

diseases these different drugs have been prescribed for.

Page 9: Shared Care Committee Polypharmacy Initiative

Discharge Summary

Admission Dx: DeliriumDischarge Diagnosis: Urosepsis

PMH:1) Alzheimer’s2) COPD3) IHD4) Hypertension5) Diabetes6) Remote CVA

Page 10: Shared Care Committee Polypharmacy Initiative

And No Mention of…

1) POLYPHARMACY

2) HOSPITALIZATION-ASSOCIATED DISABILITY

Page 11: Shared Care Committee Polypharmacy Initiative

MedReviews

When we do MedReviews…

… we still look at the appropriateness of each individual med in the context of the Resident and fail to address the inappropriateness of the actual Number of Meds in the context of the Resident’s Dignity and Quality of Life.

Page 12: Shared Care Committee Polypharmacy Initiative

Chemoprevention

Does not alter the All Cause Mortality!

Page 13: Shared Care Committee Polypharmacy Initiative

Summary

Count the Pills!